![Chris Fanale](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Chris Fanale
Corporate Officer/Principal bij Tremeau Pharmaceuticals, Inc.
Actieve functies van Chris Fanale
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Tremeau Pharmaceuticals, Inc.
![]() Tremeau Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tremeau Pharmaceuticals, Inc. engages in the developing and delivering of non-opioid pain therapies. The firm product includes TRM-201 (rofecoxib). The company was founded by Bradford C. Sippy and Mark H. N. Corrigan in 2016 and is headquartered in Concord, MA. | Corporate Officer/Principal | - | - |
Loopbaan van Chris Fanale
Statistieken
Internationaal
Verenigde Staten | 2 |
Operationeel
Corporate Officer/Principal | 1 |
Sectoraal
Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
Tremeau Pharmaceuticals, Inc.
![]() Tremeau Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tremeau Pharmaceuticals, Inc. engages in the developing and delivering of non-opioid pain therapies. The firm product includes TRM-201 (rofecoxib). The company was founded by Bradford C. Sippy and Mark H. N. Corrigan in 2016 and is headquartered in Concord, MA. | Health Technology |
- Beurs
- Insiders
- Chris Fanale
- Ervaring